Holen Sie sich die Stockscreener-App
224.35
1.91%
-4.37
Handel nachbörslich:
224.61
0.26
+0.12%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt ABBV?
Forum
Prognose
Dividendenhistorie
Abbvie Inc Aktie (ABBV) Neueste Nachrichten
AbbVie (NYSE:ABBV) At Midday As Traders Watch Nyse Composite Closely - Kalkine Media
AbbVie Inc. (NYSE:ABBV) Declares Quarterly Dividend of $1.73 - MarketBeat
AbbVie (NYSE:ABBV) Trading Down 2%Here's What Happened - MarketBeat
Abbvie Declares Quarterly Dividend, Payable on May 15, 2026 - marketscreener.com
AbbVie Declares Quarterly Dividend - Investing News Network
AbbVie Keeps Quarterly Dividend at $1.73 a Share, Payable May 15 to Shareholders of Record on April 15 - marketscreener.com
AbbVie declares quarterly dividend of $1.73 per share - Investing.com
AbbVie (ABBV) Maintains Quarterly Dividend of $1.73/Share - GuruFocus
The Escalator: HHS, EyePoint, AbbVie and more - Medical Marketing and Media
Ontario Teachers Pension Plan Board Purchases Shares of 235,747 AbbVie Inc. $ABBV - MarketBeat
Cumberland Partners Ltd Acquires 19,130 Shares of AbbVie Inc. $ABBV - MarketBeat
AbbVie Inc. $ABBV Position Raised by L & S Advisors Inc - MarketBeat
AbbVie Stock Is Quietly Exploding on New Drug Hype – Are You Late? - AD HOC NEWS
NewEdge Wealth LLC Acquires 75,364 Shares of AbbVie Inc. $ABBV - MarketBeat
Signet Financial Management LLC Cuts Stake in AbbVie Inc. $ABBV - MarketBeat
The Escalator: HHS, EyePoint Pharmaceuticals, AbbVie and more - Medical Marketing and Media
Evercore notes AbbVie Inc.’s (ABBV) Tremfya gains market share, but future earnings growth may be limited - MSN
Evercore Notes AbbVie Inc.'s (ABBV) Tremfya Gains Market Share, But Future Earnings Growth May Be Limited - Finviz
Evercore Notes AbbVie Inc.’s (ABBV) Tremfya Gains Market Share, But Future Earnings Growth May Be Limited - Insider Monkey
AbbVie (NYSE:ABBV) Shares Down 1.7%Here's What Happened - MarketBeat
Hot Picks: Microsoft, AbbVie and PNC highlight dividend growth in AI - BNN Bloomberg
Piper Sandler Raises AbbVie's (ABBV) Price Target to $299 with O - GuruFocus
Waycross Partners LLC Purchases 8,077 Shares of AbbVie Inc. $ABBV - MarketBeat
First National Bank of Omaha Takes $6.60 Million Position in AbbVie Inc. $ABBV - MarketBeat
Ingalls & Snyder LLC Increases Stock Position in AbbVie Inc. $ABBV - MarketBeat
AbbVie Inc. $ABBV is Advisors Capital Management LLC's 5th Largest Position - MarketBeat
Piper Sandler Adjusts Price Target on AbbVie to $299 From $289, Maintains Overweight Rating - marketscreener.com
Alzheimer's Therapeutics Market Research Report 2026-2036: Growing Global Burden of Alzheimer's Continues to Drive Demand - GlobeNewswire Inc.
The Zacks Analyst Blog AbbVie, RTX, International Business Machines, EVI Industries, and Rocky Mountain Chocolate Factory - Nasdaq
Top Analyst Reports for AbbVie, RTX & IBM - Yahoo Finance Singapore
Assessing AbbVie (ABBV) Valuation After Strong Results And New Rinvoq Vitiligo Filings - Yahoo Finance
AbbVie stock rises as ABBV investors brace for Feb 20 inflation read and Botox pricing fight - Bez Kabli
10 Health Care Stocks With Whale Alerts In Today's Session - Benzinga
Mubadala Investment Co PJSC reports share stake in Pfizer, AbbVie, dissolves in Merck, Dell - marketscreener.com
Mubadala Investment Co Pjsc Reports Share Stake In Pfizer, Abbvie, Dissolves in Merck, Dell - TradingView
HSBC Adjusts Price Target on AbbVie to $275 From $265, Maintains Buy Rating - marketscreener.com
AbbVie Down Since Q4 Earnings Report: How to Play the Stock - Yahoo Finance
AbbVie Inc. $ABBV Shares Bought by NEOS Investment Management LLC - MarketBeat
Skandinaviska Enskilda Banken AB publ Has $219.56 Million Stock Holdings in AbbVie Inc. $ABBV - MarketBeat
AbbVie Inc. $ABBV Shares Purchased by Colrain Capital LLC - MarketBeat
Cardano Risk Management B.V. Boosts Stake in AbbVie Inc. $ABBV - MarketBeat
Glenview Trust Co Has $95.89 Million Stake in AbbVie Inc. $ABBV - MarketBeat
Arvest Bank Trust Division Cuts Stock Position in AbbVie Inc. $ABBV - MarketBeat
AbbVie: Dominating Immunology While Building Oncology Upside (NYSE:ABBV) - Seeking Alpha
AbbVie stock: ABBV heads into Tuesday restart after $231.50 close as Botox pricing fight lingers - Bez Kabli
AbbVie Inc. $ABBV Stake Cut by Zions Bancorporation National Association UT - MarketBeat
AbbVie Inc. $ABBV Shares Sold by M&G PLC - MarketBeat
Uterine Fibroid Market Size to Reach USD 9.43 Billion by 2033 with 7.63% CAGR – SNS Insider - GlobeNewswire Inc.
AbbVie Inc. $ABBV Position Boosted by Southeast Asset Advisors LLC - MarketBeat
Mmbg Investment Advisors CO. Has $3.96 Million Holdings in AbbVie Inc. $ABBV - MarketBeat
Vanguard Group Inc. Acquires 448,554 Shares of AbbVie Inc. $ABBV - MarketBeat
AbbVie Conference: Year-End HS Readouts, SubQ SKYRIZI Data and New IBD Combo Roadmap in Focus - MarketBeat
AbbVie Inc. $ABBV Shares Purchased by Capital Planning Advisors LLC - MarketBeat
AbbVie Inc. $ABBV Shares Acquired by Fifth Third Bancorp - MarketBeat
AbbVie Inc. (NYSE:ABBV) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
Where is AbbVie Inc. (ABBV) headed according to the Street? - MSN
1 No-Brainer Dividend Stock to Buy on the Dip - The Globe and Mail
AbbVie stock ends higher Friday; what traders watch for ABBV after the Presidents Day break - TechStock²
AbbVie Inc. $ABBV Shares Bought by State of New Jersey Common Pension Fund D - MarketBeat
Shell Asset Management Co. Trims Stake in AbbVie Inc. $ABBV - MarketBeat
PNC Financial Services Group Inc. Grows Stock Position in AbbVie Inc. $ABBV - MarketBeat
Investment Partners LTD. Sells 13,247 Shares of AbbVie Inc. $ABBV - MarketBeat
HighTower Advisors LLC Raises Stock Holdings in AbbVie Inc. $ABBV - MarketBeat
GF Fund Management CO. LTD. Purchases 5,709 Shares of AbbVie Inc. $ABBV - MarketBeat
Assetmark Inc. Increases Stock Position in AbbVie Inc. $ABBV - MarketBeat
ABN Amro Investment Solutions Has $14.53 Million Stock Holdings in AbbVie Inc. $ABBV - MarketBeat
Aberdeen Group plc Sells 67,321 Shares of AbbVie Inc. $ABBV - MarketBeat
AbbVie’s Botox Lawsuit Puts Medicare Pricing Risks In Focus - Yahoo Finance
AbbVie (ABBV) stock price closes near $232 after immunology pipeline talk — what to watch next week - Bez Kabli
DDD Partners LLC Cuts Stock Position in AbbVie Inc. $ABBV - MarketBeat
AbbVie stock price climbs again after Botox lawsuit; what ABBV traders watch next - Bez Kabli
0.02%
0.16%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):